Suramin sodium (Kuzani Pharmaceuticals)

苏拉明钠 (Kuzani Pharmaceuticals)

Report date: 2025/04/20 20:00:03

Base Information

Drug NameSuramin sodium (Kuzani Pharmaceuticals)
Drug Alias NameKZ-101
ClassificationSmall molecules
Mechanisms of ActionHeparanase inhibitors
TargetsHeparanase
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKuzani Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A